Charles River Laboratories International Earnings & Revenue FAQ
What were CRL's earnings last quarter?
On Invalid Date, Charles River Laboratories International (NYSE: CRL) reported Q4 2022 earnings per share (EPS) of $3.69, up 35.16% year over year. Total Charles River Laboratories International earnings for the quarter were $187.41 million. In the same quarter last year, Charles River Laboratories International's earnings per share (EPS) was $2.73.
As of Q1 2023, Charles River Laboratories International's earnings has grown 23.17% year over year. This is 18.09 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 5.08%. Charles River Laboratories International's earnings in the past year totalled $486.23 million.
What is CRL's earnings date?
Charles River Laboratories International's earnings date is Invalid Date. Add CRL to your watchlist to be reminded of CRL's next earnings announcement.
What was CRL's revenue last quarter?
On Invalid Date, Charles River Laboratories International (NYSE: CRL) reported Q4 2022 revenue of $1.10 billion up 21.52% year over year. In the same quarter last year, Charles River Laboratories International's revenue was $905.05 million.
What was CRL's revenue growth in the past year?
As of Q1 2023, Charles River Laboratories International's revenue has grown 12.31% year over year. This is 1.7 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 10.61%. Charles River Laboratories International's revenue in the past year totalled $3.98 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.